KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 114 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $131,257 | +496.6% | 38,605 | +681.3% | 0.00% | – |
| Q2 2022 | $22,000 | -95.6% | 4,941 | -80.9% | 0.00% | -100.0% |
| Q1 2020 | $496,000 | -96.8% | 25,818 | -96.8% | 0.00% | -97.1% |
| Q4 2019 | $15,667,000 | +2822.9% | 817,261 | +790.4% | 0.04% | +3400.0% |
| Q1 2019 | $536,000 | -80.5% | 91,782 | -68.7% | 0.00% | -85.7% |
| Q4 2018 | $2,749,000 | -45.4% | 293,399 | -0.8% | 0.01% | -41.7% |
| Q3 2018 | $5,038,000 | +11895.2% | 295,854 | +11995.4% | 0.01% | – |
| Q2 2018 | $42,000 | +1300.0% | 2,446 | +1037.7% | 0.00% | – |
| Q1 2018 | $3,000 | – | 215 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |